Distinguished Advisory Group
We are supported by an extensive group of trusted advisors with expertise in all areas of pharmaceutical sciences, including regulatory affairs, drug delivery, pharmacology, skin diseases, nanotechnology, prodrugs, digital R&D, and gene therapy.
Ian Wilding, PhD – FDA consultant in biopharmaceutics, world-renowned oral drug delivery expert, entrepreneur and board member in the United Kingdom
Daan Crommelin, PhD – prof. emeritus U. Utrecht in The Netherlands, nanotechnology and protein pharmaceuticals, complex drug product regulatory CMC expert, mRNA product advisor to the WHO
Eric Jacquinet, DVM, PhD, DABT – pharmacology, toxicology, pathology, preclinical discovery and drug development
Dan Deaver, PhD – 40+ years academic and industry expertise, in vivo pharmacology, toxicology consultant, including prodrugs, complex injectables
Jóhann E. Guðjónsson, MD, PhD – Arthur C Curtis Prof. of Skin Molecular Immunology, Prof. Dermatology; U. Michigan
Iain McFadyen, PhD – CD(S)O with a proven track record of building, leading, and developing impactful computational sciences and digital systems teams
Magali B. Hickey, PhD – Seasoned Pharmaceutical R&D leader in drug delivery and nanotechnology product development
Gabor Butora, PhD – 30 years of pharmaceutical experience in medicinal and process chemistry, including nucleotide chemistry and lipid technologies
© 2026 Axelyf, Inc.